On August 5, Stephanie Link, Hightower Advisors’ chief investment strategist, joined ‘Squawk Box’ on CNBC to suggest that she expects market volatility for the next 2 months, but set up into year-end is positive. Link confirmed that 66% of companies had reported their earnings at the time, with 82% of them beating on the top line and 68% beating on the bottom line. She added that year-over-year growth is running at 8.2%, which she considered pretty good. She expressed displeasure with the stock market’s reaction to the reports but noted that the market was up about 29% before the reports came out, so some of the gains were being given back. Link believes that earnings will eventually matter and predicted that the next 2 months will be volatile, which is a period that is not seasonally strong for the markets.

She cited the Jackson Hole Economic Symposium and uncertainty about the Fed’s future actions as contributing factors. Despite the short-term volatility, she was optimistic about the market’s setup for the rest of the year and suggested that investors take advantage of opportunities in stocks like the MAG7 companies, which have reported phenomenal numbers. Link also said that many people are not talking about the positive impacts of tariffs, such as on-shoring and re-shoring manufacturing to the US. She connected this to the significant CapEx being made by the MAG7 companies, which she stated are planning to spend $400 billion on AI and CapEx this year alone. She said that this is more than the EU’s total defense spending, putting the number in perspective. She concluded by saying that while there is nervousness about the inflationary effects of tariffs, the growth they spur should be welcomed.

That being said, we’re here with a list of the 14 best high volume stocks to invest in.

Our Methodology

We first used the Yahoo stock screener to compile a list of stocks with high average 3-month volumes (at least 5 million). We then selected the 14 stocks that were the most popular among elite hedge funds and that analysts were bullish on. The stocks are ranked in ascending order of the number of hedge funds that have stakes in them, as of Q1 2025.

Note: All data was collected on August 12.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).

14 Best High Volume Stocks to Invest In

14. Tesla Inc. (NASDAQ:TSLA)

Average Volume (3-Month): 104.72 million

Number of Hedge Fund Holders: 104

Tesla Inc. (NASDAQ:TSLA) is one of the best high-volume stocks to invest in. On August 11, it was reported that Elon Musk’s company, Tesla, is moving to enter the British energy market and has applied for an energy supply license from the regulator Ofgem. The application was filed last month by a subsidiary called Tesla Energy Ventures and was signed by Andrew Payne, who is the director of the group’s energy business in Europe.

If approved, Tesla hopes to begin supplying energy to homes and businesses in England, Scotland, and Wales as soon as next year. This move would position the company to compete directly with existing energy suppliers such as British Gas owner Centrica and Octopus Energy. The decision to enter the UK energy market comes amidst a period of declining demand for Tesla’s electric vehicles in Europe.

Tesla’s involvement in the UK energy market dates back to 2020, when it was granted a license to be an electricity generator. The company also operates a solar energy and battery storage business. In the US, Tesla has been an electricity supplier in Texas for the past 3 years. The push to expand into the British energy market comes ~2 years after Tesla first started hiring a head of operations for a proposed energy supply business.

Tesla Inc. (NASDAQ:TSLA) designs, develops, manufactures, leases, and sells EVs, and energy generation & storage systems in the US, China, and internationally.

13. Boston Scientific Corporation (NYSE:BSX)

Average Volume (3-Month): 7.45 million

Number of Hedge Fund Holders: 108

Boston Scientific Corporation (NYSE:BSX) is one of the best high-volume stocks to invest in. On August 6, the FDA announced that it is monitoring a safety issue with Boston Scientific Corporation’s ENDOTAK RELIANCE defibrillation leads, which are used with implantable cardioverter-defibrillators to prevent sudden cardiac death.

Earlier this year, the company sent a letter to healthcare providers on July 24, warning that calcification of the leads’ expanded polytetrafluoroethylene/ePTFE coating could lead to a gradual increase in low-voltage shock impedance/LVSI. This can reduce the effectiveness of life-saving shocks and even result in patient death.

The affected leads were manufactured and distributed between 2002 and 2021 and are no longer available. As of July 24, Boston Scientific had reported 386 serious injuries and 16 deaths linked to this issue. The FDA has categorized this as a potentially high-risk problem and is actively reviewing data to determine further regulatory action.

Boston Scientific Corporation (NYSE:BSX) develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It has 2 segments: MedSurg and Cardiovascular.